| ISS on its own Stimulates Dynavax and AstraZeneca to collaborate on Asthma |
Abstract
pdf
|
|
Business Review Editor |
|
| Drastic Measures: Ligand Sells All its Marketed Products |
Abstract
pdf
|
|
Business Review Editor |
|
| A Hostile Genzyme and AnorMED Unrest: Changing Times for the Biotech Industry
|
Abstract
pdf
|
|
Business Review Editor |
|
| Paying the Right Price in Biotech Acquisitions |
Abstract
pdf
|
|
Business Review Editor |
|
| Therapy Focus: Wound Care |
Abstract
pdf
|
|
Business Review Editor |
|
| GSK Loads up the Potential Milestones from Chemocentryx |
Abstract
pdf
|
|
Business Review Editor |
|
| Apotex vs. Large Pharma: The Battle Continues |
Abstract
|
|
Business Review Editor |
|
| Salix Licenses Right to Market and Distribute SanvarĀ® from Debiopharm |
Abstract
pdf
|
|
Business Review Editor |
|
| Controlling Value in Deals |
Abstract
html
|
|
Fintan Walton |
|
| Serono Changes Tack Again and Finds Buyer |
Abstract
pdf
|
|
Business Review Editor |
|
| Hospira to Acquire Mayne Pharma |
Abstract
pdf
|
|
Business Review Editor |
|